Annual report
2901.TEDINET S100W0NH
Period2024-04-01 → 2025-03-31
Filed2025-06-20
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 169
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥201m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥122m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥48m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥48m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥170m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥169m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥145m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥118m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥138m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥445m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥350m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥432m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥431m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥352m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥351m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥115m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥158m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥108m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥432m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | −¥352m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥4.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total assets | ¥880m | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥880m | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total assets | ¥890m | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥954m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.7bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Net assets / equity | −¥73m | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | −¥73m | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥134m | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥133m | at 2023-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥252m | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥45m | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥224m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥214m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥214m | at 2024-03-31 | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥211m | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥211m | at 2023-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥512m | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥490m | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥24m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥24m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥37m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥36m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥365m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥266m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥37m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥36m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥35m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥51m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥50m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥19m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥166m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥146m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥789m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥789m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥90m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥90m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥43m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥122m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥497m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥25.44 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.58 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.06 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.3 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-15.28 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥21.77 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥129.95 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥-5.01 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥9.14 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥17.7 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3.96 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 58.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | -8.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.7% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.0% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 4.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 31.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 70 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 57 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 55 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 68 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 48 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥219m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥218m | 2023-04-01 → 2024-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥852m | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥292m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥287m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥162m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥147m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥91m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥90m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥163m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥162m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥151m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥124m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥135m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥273m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥342m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥272m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥271m | 2024-04-01 → 2025-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥343m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥342m | 2023-04-01 → 2024-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥121m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥172m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥146m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥4.0bn | at 2025-03-31 | Standalone | Total assets (5-year summary) |
| Total assets | ¥630m | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥629m | at 2024-03-31 | Standalone | Total assets (5-year summary) |
| Total assets | ¥639m | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥752m | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥590m | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.3bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥521m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.8bn | at 2025-03-31 | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥109m | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥108m | at 2024-03-31 | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥302m | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥301m | at 2023-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥419m | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥246m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥707m | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥47m | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥16.03 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.97 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.5 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.47 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.62 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.72 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥2 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥134.14 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥6.89 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥20.88 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥29.38 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥21.52 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.7% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.9% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 20,557,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 15,295,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,295,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,295,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,437,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 7 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 6 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 4 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 7 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 7 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥14m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥807,000 |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥188m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥31m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥808m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥95m |
| Internet Shopping Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2m |
| Internet Shopping Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥568m |
| Internet Shopping Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥568m |
| Internet Shopping Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥4m |
| Medical And Cosmeticsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5m |
| Medical And Cosmeticsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3m |
| Medical And Cosmeticsreportable segment | employees | at 2025-03-31 | 21 pure |
| Medical And Cosmeticsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥262m |
| Medical And Cosmeticsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥262m |
| Medical And Cosmeticsreportable segment | segment assets | at 2025-03-31 | ¥1.2bn |
| Medical And Cosmeticsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥76m |
| Wellnessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥6m |
| Wellnessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥104,000 |
| Wellnessreportable segment | employees | at 2025-03-31 | 46 pure |
| Wellnessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Wellnessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Wellnessreportable segment | segment assets | at 2025-03-31 | ¥2.6bn |
| Wellnessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥214m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥10m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥5m |
| —segment total | employees | at 2025-03-31 | 67 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| —segment total | segment assets | at 2025-03-31 | ¥3.8bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥295m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥10m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥296m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥29m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥29m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥936,000 |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥1m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥100m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥88m |
| Internet Shopping Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥6m |
| Internet Shopping Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Internet Shopping Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Internet Shopping Businessreportable segment | segment assets | at 2024-03-31 | ¥311m |
| Internet Shopping Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥5m |
| Medical And Cosmeticsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥12m |
| Medical And Cosmeticsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥12m |
| Medical And Cosmeticsreportable segment | segment assets | at 2024-03-31 | ¥357m |
| Medical And Cosmeticsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥33m |
| Wellnessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥9m |
| Wellnessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥387,000 |
| Wellnessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥314m |
| Wellnessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥314m |
| Wellnessreportable segment | segment assets | at 2024-03-31 | ¥112m |
| Wellnessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥4m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥9m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥6m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.0bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.0bn |
| —segment total | segment assets | at 2024-03-31 | ¥781m |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | −¥31m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥781m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | −¥33m |
| Medical And Cosmeticsreportable segment | employees | at 2025-03-31 | 2 pure |
| Wellnessreportable segment | employees | at 2025-03-31 | 2 pure |
| —segment total | employees | at 2025-03-31 | 4 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,459
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior1YearInstant | 880000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 4574000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 3.96 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 17.70 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 9.14 | |
| Net assets per share (5-year summary) | Prior1YearInstant | -5.01 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 129.95 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | -15.28 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | -13.30 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | -8.06 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -24.58 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 25.44 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | 21.77 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.042 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.250 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.147 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | -0.087 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.584 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | － | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.315 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 27.90 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | -37000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | -266000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -365000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -36000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 24000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -146000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | 166000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | 19000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -50000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | 35000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 497000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 122000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 43000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 90000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | 789000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 490000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 512000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 211000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass rounding |
| statement vs summary · net assets | pass rounding |
| statement vs summary · net assets | pass rounding |
| statement vs summary · net assets | pass rounding |
| statement vs summary · net assets | pass rounding |
| statement vs summary · net assets | pass rounding |
| statement vs summary · net income attributable to parent | pass rounding |
| statement vs summary · net income attributable to parent | pass rounding |
| statement vs summary · operating cash flow | pass rounding |
| statement vs summary · operating cash flow | pass rounding |
| statement vs summary · revenue | pass rounding |
| statement vs summary · revenue | pass rounding |
| statement vs summary · revenue | pass rounding |
| statement vs summary · revenue | pass rounding |
| statement vs summary · total assets | pass rounding |
| statement vs summary · total assets | pass rounding |
| statement vs summary · total assets | pass rounding |
| statement vs summary · total assets | pass rounding |